Trials / Recruiting
RecruitingNCT06843512
Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Penn State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GLP-1 Medication Initiation | One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits. |
Timeline
- Start date
- 2025-07-15
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-02-25
- Last updated
- 2025-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06843512. Inclusion in this directory is not an endorsement.